FDA Set to Authorize Pfizer Vaccine for Adolescents, But Some Experts Question Need, Ethics

The U.S Food and Drug Administration could by early next week expand Pfizer’s Emergency Use Authorization to include children ages 12 to 15, an age group whose risk of dying from COVID is less than 0.1%